findmyKOL

Yassar Chakfe, MD

Basic profile

University of Central Florida

ORCIDNone on fileNPI
RegionOrlando, FL · SoutheastSpecialtyNeurologyFocusNeurology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2019Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Yassar Chakfe is a Neurology physician affiliated with University of Central Florida. OpenAlex indexes 11 publications with 520 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
11publications

Distinct works indexed by OpenAlex.

520citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

4359 Hunters Park Ln
Orlando, FL 32837

Telephone

407-251-6511

Provider last certified this registry record 14 Jul 2023.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    85.2%
    N-methyl-D-aspartate Receptor Antagonist13.6%
    Memantine Hcl70%Memantine Hcl Er30%
    Part D72 patients
    Gabapentinoids10%
    Gabapentin89%Pregabalin11%
    Part D76 patients

    + 16 more classes in this area

  • Musculoskeletal

    8.6%
    Muscle Relaxant4.3%
    Cyclobenzaprine Hcl70%Methocarbamol17%Metaxalone14%
    Part D<11 patients
    Central alpha-2 Adrenergic Agonist3.1%
    Tizanidine Hcl100%
    Part D25 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2.3%
    Corticosteroid1.4%
    Prednisone100%
    Part D<11 patients
    Serotonin-3 Receptor Antagonist0.9%
    Ondansetron Odt100%
    Part D<11 patients
Where care is delivered (Part B)13.6% facility · 86.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”